Skip to content
HUB Organoids
services
services overview
drug screening
model and assay development
clinical trials in a dish
technology
company
about us
careers
events
latest news
resources
license program
contact
Resources
July 6, 2022
Patient-derived organoids as a model for treatment diagnosis in Cystic Fibrosis – combinatory treatment with read-through agent, correctors and potentiator on rare mutations
read more
June 3, 2022
Patient in the lab: predicting clinical responses using patient-derived organoid screening
read more
June 3, 2022
Patient-derived organoids predict clinical response: a patient in the lab
read more
June 3, 2022
Application of HUB Organoids® to Immunotherapy development
read more
February 17, 2022
HUB Organoids applications to drug safety and ADME evaluation
read more
February 17, 2022
Potential of liver organoids in preclinical evaluation of toxicity, safety and mode of action
read more
X
Have any questions?
